Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Tettero, J."'
S130: NPM1 MUTATED AML: IMPACT OF CO‐MUTATIONAL PATTERNS ‐ RESULTS OF THE EUROPEAN HARMONY ALLIANCE.
Autor:
Hernández‐Sánchez, A., Villaverde‐Ramiro, Á., Martínez Elicegui, J., González, T., Benner, A., Sträng, E., Castellani, G., Heckman, C. A., Versluis, J., Abáigar, M., Sobas, M., Azibeiro, R., Tur, L., Valk, P. J., Metzeler, K. H., Ayala, R., Dall'Olio, D., Tettero, J., Martínez‐López, J., Dombret, H.
Publikováno v:
HemaSphere; 2022 Supplement 3, Vol. 6, p31-32, 2p
Autor:
Tembhare, Prashant Ramesh1 (AUTHOR)
Publikováno v:
Indian Journal of Medical & Paediatric Oncology. Dec2023, Vol. 44 Issue 6, p554-565. 12p.
Autor:
Tettero JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Dakappagari N; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Heidinga ME; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Oussoren-Brockhoff Y; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hanekamp D; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Pahuja A; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Burns K; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Kaur P; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Alfonso Z; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Te Marvelde JG; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Hobo W; Department of Laboratory Medicine-Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Slomp J; Department of Clinical Chemistry, Medisch Spectrum Twente/Medlon, Enschede, The Netherlands., Bachas C; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Nguyen K; Navigate BioPharma (a Novartis Subsidiary), Carlsbad, California, USA., Cloos J; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Nov; Vol. 104 (6), pp. 426-439. Date of Electronic Publication: 2023 Sep 28.
Autor:
Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jorgensen JL; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jia F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Sep; Vol. 104 (5), pp. 356-366. Date of Electronic Publication: 2023 Aug 22.
Autor:
Chomczyk, Monika, Gazzola, Luca, Dash, Shubhankar, Firmanty, Patryk, George, Binsah S., Mohanty, Vakul, Abbas, Hussein A., Baran, Natalia
Publikováno v:
Frontiers in Pharmacology; 2024, p01-16, 16p
Autor:
Reuvekamp T; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location Universiteit van Amsterdam, Amsterdam, The Netherlands., Janssen LLG; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ngai LL; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Carbaat-Ham J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., den Hartog D; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Scholten WJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Kelder A; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Hanekamp D; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute and University Medical Center Rotterdam, Rotterdam, The Netherlands., Wensink E; Department of Radiology and Nuclear Medicine, Amsterdam UMC location Universiteit van Amsterdam, Amsterdam, The Netherlands., van Gils N; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Gradowska P; Department of Hematology, Erasmus MC Cancer Institute and University Medical Center Rotterdam, Rotterdam, The Netherlands.; HOVON Foundation, Rotterdam, The Netherlands., Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute and University Medical Center Rotterdam, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Westers TM; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Smit L; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bachas C; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Cloos J; Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.
Autor:
Sefland Ø; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Gullaksen SE; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway., Omsland M; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Safety, Chemistry, and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway., Reikvam H; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Galteland E; Department of Haematology, Oslo University Hospital, Oslo, Norway., Tran HTT; Department of Haematology, Akershus University Hospital, Lørenskog, Norway., Spetalen S; Department of Pathology, Oslo University Hospital, Oslo, Norway., Singh SK; Mendus A.B., Stockholm, Sweden., Van Zeeburg HJT; Mendus A.B., Stockholm, Sweden., Van De Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands., Gjertsen BT; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medicine, Section of Hematology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul 30. Date of Electronic Publication: 2024 Jul 30.
Autor:
Shopsowitz K; Division of Hematopathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.; Department of pathology and laboratory medicine, University of British Columbia, Vancouver, British Columbia, Canada., Lofroth J; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Chan G; Division of Hematopathology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Kim J; Terry Fox Lab, BC Cancer, Vancouver, British Columbia, Canada., Rana M; Division of Hematopathology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Brinkman R; Terry Fox Lab, BC Cancer, Vancouver, British Columbia, Canada., Weng A; Department of pathology and laboratory medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Terry Fox Lab, BC Cancer, Vancouver, British Columbia, Canada., Medvedev N; Division of Hematopathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.; Department of pathology and laboratory medicine, University of British Columbia, Vancouver, British Columbia, Canada., Wang X; Division of Hematopathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.; Department of pathology and laboratory medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul; Vol. 106 (4), pp. 239-251. Date of Electronic Publication: 2024 Feb 28.
Autor:
Tettero, Jesse M., Al-Badri, Waleed K. W., Ngai, Lok Lam, Bachas, Costa, Breems, Dimitri A., van Elssen, Catharina H. M. J., Fischer, Thomas, Gjertsen, Bjorn T., van Gorkom, Gwendolyn N. Y., Gradowska, Patrycja, Greuter, Marjolein J. E., Griskevicius, Laimonas, Juliusson, Gunnar, Maertens, Johan, Manz, Markus G., Pabst, Thomas, Passweg, Jakob, Porkka, Kimmo, Löwenberg, Bob, Ossenkoppele, Gert J.
Publikováno v:
Frontiers in Oncology; 10/10/2022, Vol. 12, p1-11, 11p